News
Tailoring Cognitive Behavioral Therapy to PNES, Seizure-Related Disorders, Becky Tilahun, PhD
January 6th 2022The clinical psychologist at Cleveland Clinic discussed the process for successfully changing and tailoring different cognitive behavioral therapy approaches to treat various forms of seizures. [WATCH TIME: 3 minutes]
Need for Guidelines on Migraine in Emergency Department Settings
January 6th 2022Anne-Maree Kelly, MD, director, Joseph Epstein Center for Emergency Medicine Research, detailed the complexities of presenting migraine in the emergency department and why consensus international/national guidelines tailorable to the capabilities of institutions is necessary.
Dispelling Myths About Dietitians in Multiple Sclerosis Care: Mona Bostick, RDN, LDN, MSCS
January 5th 2022The founder of MS Bites discussed the role of referrals both to and from dietitians, as well as the common misconception that their services are not covered by insurance. [WATCH TIME: 2 minutes]
MS Disease-Modifying Therapy Discontinuation Associated With Disability Progression
January 5th 2022DMT discontinuation resulted with new disability worsening and/or progression in previously stable patients with relapsing-remitting MS and particularly in patients with previously stable secondary progressive MS.
Eliminating Wasteful Costs in Alzheimer Drug Development: Jeffrey Cummings, MD, ScD
January 5th 2022The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas detailed the steps necessary to lower wasted costs from Alzheimer disease drug development and improve regulatory success. [WATCH TIME: 4 minutes]
The Variation in Migraine Management in Emergency Departments: Anne-Maree Kelly, MD
January 4th 2022The director of the Joseph Epstein Center for Emergency Medicine Research provided context on the types of research needed to further evaluate and improve diagnosis and management of headache in emergency departments. [WATCH TIME: 3 minutes]
Mechanical Thrombectomy Shows Functional Benefit for Large Vessel Occlusion
January 4th 2022Favorable outcome, defined as modified Rankin Scores of 0-2, was achieved in patients presenting with ASPECTS of 2-5 regardless of treatment with mechanical thrombectomy in the early or extended windows.
Understanding Cognitive Decline Based on Multiple Sclerosis Phenotype: Dejan Jakimovski, MD, PhD
January 4th 2022The research assistant professor at the Buffalo Neuroimaging Analysis Center provided context on how different forms of multiple sclerosis impact cognitive decline in patients. [WATCH TIME: 3 minutes]
Antiseizure Medications Display Mortality Differences in Poststroke Epilepsy
January 4th 2022The study authors concluded that while there are differences in survival between specific ASMs, lamotrigine and levetiracetam appear to be reasonable first-line treatment options for patients with poststroke epilepsy.
Differentiating Diet Approaches in Multiple Sclerosis: Mona Bostick, RDN, LDN, MSCS
January 3rd 2022The founder of MS Bites discussed the role dietitians can play in care of patients with MS, noting that they have not historically been included in the comprehensive care team, and differentiating their approaches to care. [WATCH TIME: 2 minutes]
Preventing TSC By Treating at the Earliest Stage: Darcy Krueger, MD, PhD
January 3rd 2022The director of the Tuberous Sclerosis Clinic at Cincinnati Children’s discussed the thought behind STOPS2, a trial aimed at preventing or delaying seizure onset in tuberous sclerosis complex. [WATCH TIME: 3 minutes]
